Comparative In Vitro Study of Various α(2)-Adrenoreceptor Agonist Drugs for Ticagrelor Reversal

Ticagrelor, an antiplatelet adenosine diphosphate (ADP)-P2Y(12) receptor antagonist, increases the risk of bleeding. Its management is challenging because platelet transfusion is ineffective and no specific antidote is currently available. Epinephrine, a vasopressor catecholamine prescribed during s...

Descripción completa

Detalles Bibliográficos
Autores principales: Porta Bonete, Guillaume, Godier, Anne, Gaussem, Pascale, Belleville-Rolland, Tiphaine, Leuci, Alexandre, Poirault-Chassac, Sonia, Bachelot-Loza, Christilla, Martin, Anne-Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141185/
https://www.ncbi.nlm.nih.gov/pubmed/32188130
http://dx.doi.org/10.3390/jcm9030809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141185/
https://www.ncbi.nlm.nih.gov/pubmed/32188130
http://dx.doi.org/10.3390/jcm9030809

Ejemplares similares